Search

Your search keyword '"Léger J"' showing total 1,461 results
Start Over Author "Léger J"
1,461 results on '"Léger J"'

6. International Geomagnetic Reference Field: the thirteenth generation

Author

Alken, P., Thébault, E., Beggan, C. D., Amit, H., Aubert, J., Baerenzung, J., Bondar, T. N., Brown, W. J., Califf, S., Chambodut, A., Chulliat, A., Cox, G. A., Finlay, C. C., Fournier, A., Gillet, N., Grayver, A., Hammer, M. D., Holschneider, M., Huder, L., Hulot, G., Jager, T., Kloss, C., Korte, M., Kuang, W., Kuvshinov, A., Langlais, B., Léger, J.-M., Lesur, V., Livermore, P. W., Lowes, F. J., Macmillan, S., Magnes, W., Mandea, M., Marsal, S., Matzka, J., Metman, M. C., Minami, T., Morschhauser, A., Mound, J. E., Nair, M., Nakano, S., Olsen, N., Pavón-Carrasco, F. J., Petrov, V. G., Ropp, G., Rother, M., Sabaka, T. J., Sanchez, S., Saturnino, D., Schnepf, N. R., Shen, X., Stolle, C., Tangborn, A., Tøffner-Clausen, L., Toh, H., Torta, J. M., Varner, J., Vervelidou, F., Vigneron, P., Wardinski, I., Wicht, J., Woods, A., Yang, Y., Zeren, Z., and Zhou, B.

Published
2021
Full Text
View/download PDF

9. Probing complex RNA structures by mechanical force

Author

Harlepp, S., Marchal, T., Robert, J., Leger, J-F., Xayaphoummine, A., Isambert, H., and Chatenay, D.

Subjects
Physics - Biological Physics, Condensed Matter - Soft Condensed Matter, Quantitative Biology - Biomolecules
Abstract

RNA secondary structures of increasing complexity are probed combining single molecule stretching experiments and stochastic unfolding/refolding simulations. We find that force-induced unfolding pathways cannot usually be interpretated by solely invoking successive openings of native helices. Indeed, typical force-extension responses of complex RNA molecules are largely shaped by stretching-induced, long-lived intermediates including non-native helices. This is first shown for a set of generic structural motifs found in larger RNA structures, and then for Escherichia coli's 1540-base long 16S ribosomal RNA, which exhibits a surprisingly well-structured and reproducible unfolding pathway under mechanical stretching. Using out-of-equilibrium stochastic simulations, we demonstrate that these experimental results reflect the slow relaxation of RNA structural rearrangements. Hence, micromanipulations of single RNA molecules probe both their native structures and long-lived intermediates, so-called "kinetic traps", thereby capturing -at the single molecular level- the hallmark of RNA folding/unfolding dynamics., Comment: 9 pages, 9 figures

Published
2003
Full Text
View/download PDF

11. Menger curvature and rectifiability

Author

Léger, J. C.

Subjects
Mathematics - Metric Geometry
Abstract

For a Borel set E in R^n, the total Menger curvature of E, or c(E), is the integral over E^3 (with respect to 1-dimensional Hausdorff measure in each factor of E) of c(x,y,z)^2, where 1/c(x,y,z) is the radius of the circle passing through three points x, y, and z in E. Let H^1(X) denote the 1-dimensional Hausdorff measure of a set X. A Borel set E in R^n is purely unrectifiable if for any Lipschitz function gamma from R to R^n, H^1(E cap gamma(R)) = 0. It is said to be rectifiable if there exists a countable family of Lipschitz functions gamma_i from R to R^n such that H^1(E - union gamma_i(R)) = 0. It may be seen from this definition that any 1-set E (that is, E Borel and 0

Published
1999

22. Insuffisance corticotrope après une corticothérapie prolongée : définition de seuils de cortisol permettant d’éviter le test au Synacthène faible dose en pédiatrie

Author

Laulhé, M., primary, Dumaine, C., additional, Chevenne, D., additional, Leye, F., additional, Faye, A., additional, Dozières, B., additional, Strullu, M., additional, Viala, J., additional, Hogan, J., additional, Houdouin, V., additional, Léger, J., additional, Simon, D., additional, Carel, J.C., additional, Storey, C., additional, Guilmin-Crépon, S., additional, and Martinerie, L., additional

Published
2022
Full Text
View/download PDF

23. Devenir des enfants traités par thyroïdectomie à visée prophylactique dans le cadre d’une NEM2 (étude du GTE)

Author

Morard, I., primary, Oliver, I., additional, Coutant, R., additional, Amouroux, C., additional, Rothenbuhler, A., additional, Marquant, E., additional, Borson-Chazot, F., additional, Castanet, M., additional, Baron, S., additional, De Kerdanet, M., additional, Léger, J., additional, Polak, M., additional, Souchon, P.F., additional, Barat, P., additional, and Haissaguerre, M., additional

Published
2022
Full Text
View/download PDF

26. Assemblée permanente

Author

Niessen, C.R., Reuchamps, M., Petit, G., Blondiaux, L., Casillo, I., Fourniau, J.-M., Gourgues, G., Hayat, S., Lefebvre, R., Rui, S., Wojcik, S., Zetlaouï-Léger, J., Petit, G., Blondiaux, L., Casillo, I., Fourniau, J.-M., Gourgues, G., Hayat, S., Lefebvre, R., Rui, S., Wojcik, S., and Zetlaouï-Léger, J.

Published
2022

29. Assessment of the automated multiplex-PCR Unyvero i60 ITI® cartridge system to diagnose prosthetic joint infection: a multicentre study

Author

Cottin, J., Ducellier, F., Abgueguen, P., Balan, V., Stindel, E., Ansart, S., Greves, A., Aubin, G., Touchais, S., Gouin, F., Boutoille, D., Asseray, N., Happi, L., Guinard, J., Razanabola, F., Mille, C., Cognée, A.S., Gayet, L.E., Le Moal, G., Thomas, C., Polard, J.L., Arvieux, C., Meheut, A., Bernard, L., Rosset, P., Gras, G., Druon, J., Fèvre, K., Malandain, D., Bémer, P., Leroy, A.G., Léger, J., Plouzeau, C., Valentin, A.S., Jolivet-Gougeon, A., Tandé, D., Héry-Arnaud, G., Lemarié, C., Kempf, M., Bret, L., Burucoa, C., and Corvec, S.

Published
2018
Full Text
View/download PDF

30. Prenatal dexamethasone treatment for classic 21-hydroxylase deficiency in Europe

Author

Nowotny, H., Neumann, U., Tardy-Guidollet, V., Ahmed, S.F., Baronio, F., Battelino, T., Bertherat, J., Blankenstein, O., Bonomi, M., Bouvattier, C., Perrière, A. Brac de la, Brucker, S., Cappa, M., Chanson, P., Claahsen-van der Grinten, H.L., Colao, A., Cools, M., Davies, J.H., Dörr, H.G., Fenske, W.K., Ghigo, E., Giordano, R., Gravholt, C.H., Huebner, A., Husebye, E.S., Igbokwe, R., Juul, A., Kiefer, F.W., Léger, J., Menassa, R., Meyer, G., Neocleous, V., Phylactou, L.A., Rohayem, J., Russo, G., Scaroni, C., Touraine, P., Unger, N., Vojtková, J., Yeste, D., Lajic, S., Reisch, N., Nowotny, H., Neumann, U., Tardy-Guidollet, V., Ahmed, S.F., Baronio, F., Battelino, T., Bertherat, J., Blankenstein, O., Bonomi, M., Bouvattier, C., Perrière, A. Brac de la, Brucker, S., Cappa, M., Chanson, P., Claahsen-van der Grinten, H.L., Colao, A., Cools, M., Davies, J.H., Dörr, H.G., Fenske, W.K., Ghigo, E., Giordano, R., Gravholt, C.H., Huebner, A., Husebye, E.S., Igbokwe, R., Juul, A., Kiefer, F.W., Léger, J., Menassa, R., Meyer, G., Neocleous, V., Phylactou, L.A., Rohayem, J., Russo, G., Scaroni, C., Touraine, P., Unger, N., Vojtková, J., Yeste, D., Lajic, S., and Reisch, N.

Abstract

Contains fulltext : 283126.pdf (Publisher’s version ) (Open Access), OBJECTIVE: To assess the current medical practice in Europe regarding prenatal dexamethasone (Pdex) treatment of congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency. DESIGN AND METHODS: A questionnaire was designed and distributed, including 17 questions collecting quantitative and qualitative data. Thirty-six medical centres from 14 European countries responded and 30 out of 36 centres were reference centres of the European Reference Network on Rare Endocrine Conditions, EndoERN. RESULTS: Pdex treatment is currently provided by 36% of the surveyed centres. The treatment is initiated by different specialties, that is paediatricians, endocrinologists, gynaecologists or geneticists. Regarding the starting point of Pdex, 23% stated to initiate therapy at 4-5 weeks postconception (wpc), 31% at 6 wpc and 46 % as early as pregnancy is confirmed and before 7 wpc at the latest. A dose of 20 µg/kg/day is used. Dose distribution among the centres varies from once to thrice daily. Prenatal diagnostics for treated cases are conducted in 72% of the responding centres. Cases treated per country and year vary between 0.5 and 8.25. Registries for long-term follow-up are only available at 46% of the centres that are using Pdex treatment. National registries are only available in Sweden and France. CONCLUSIONS: This study reveals a high international variability and discrepancy in the use of Pdex treatment across Europe. It highlights the importance of a European cooperation initiative for a joint international prospective trial to establish evidence-based guidelines on prenatal diagnostics, treatment and follow-up of pregnancies at risk for CAH.

Published
2022

31. 2022 European Thyroid Association Guideline for the management of pediatric Graves’ disease

Author

Mooij, C. F., Cheetham, T. D., Verburg, F. A., Eckstein, A., Pearce, S. H., Léger, J., van Trotsenburg, A. S. P., Mooij, C. F., Cheetham, T. D., Verburg, F. A., Eckstein, A., Pearce, S. H., Léger, J., and van Trotsenburg, A. S. P.

Abstract

Hyperthyroidism caused by Graves’ disease (GD) is a relatively rare disease in children. Treatment options are the same as in adults – antithyroid drugs (ATD), radioactive iodine (RAI) or thyroid surgery, but the risks and benefits of each modality are different. The European Thyroid Association guideline provides new recommendations for the management of pediatric GD with and without orbitopathy. Clinicians should be alert that GD may present with behavioral changes or declining academic performance in children. Measurement of serum TSH receptor antibodies is recommended for all pediatric patients with hyperthyroidism. Management recommendations include the first-line use of a prolonged course of methimazole/carbimazole ATD treatment (3 years or more), a preference for dose titration instead of block and replace ATD, and to avoid propylthiouracil use. Where definitive treatment is required either total thyroidectomy or RAI is recommended, aiming for complete thyroid ablation with a personalized RAI activity. We recommend avoiding RAI in children under 10 years of age but favor surgery in patients with large goiter. Pediatric endocrinologists should be involved in all cases.

Published
2022

43. 481P Evaluation of serum mid-infrared spectroscopy as new prognostic marker for bevacizumab-based chemotherapy in first-line treatment of metastatic colorectal cancer

Author

Chautard, R., primary, Léger, J., additional, Bouche, O., additional, Borg, C., additional, Douillard, J-Y., additional, Manfredi, S., additional, Terrebonne, E., additional, Capitain, O., additional, Spano, J-P., additional, Caulet, M., additional, Raoul, W., additional, Guéguinou, M., additional, Hérault, O., additional, Ferru, A., additional, Pobel, C.J., additional, Sire, O., additional, and Lecomte, T., additional

Published
2021
Full Text
View/download PDF

44. Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies

Author

Merkies, Ingemar S. J., van Schaik, Ivo N., Léger, Jean-Marc, Bril, Vera, van Geloven, Nan, Hartung, Hans-Peter, Lewis, Richard A., Sobue, Gen, Lawo, John-Philip, Durn, Billie L., Cornblath, David R., De Bleecker, Jan L., Sommer, Claudia, Robberecht, Wim, Saarela, Mika, Kamienowski, Jerzy, Stelmasiak, Zbigniew, Tackenberg, Björn, Mielke, Orell, Sabet, A., George, K., Roberts, L., Carne, R., Blum, S., Henderson, R., Van Damme, P., Demeestere, J., Larue, S., D'Amour, C., Kunc, P., Valis, M., Sussova, J., Kalous, T., Talab, R., Bednar, M., Toomsoo, T., Rubanovits, I., Gross-Paju, K., Sorro, U., Saarela, M., Auranen, M., Pouget, J., Attarian, S., Masson, G. Le, Wielanek-Bachelet, A., Desnuelle, C., Delmont, E., Clavelou, P., Aufauvre, D., Schmidt, J., Zschuentzsch, J., Sommer, C., Kramer, D., Hoffmann, O., Goerlitz, C., Haas, J., Chatzopoulos, M., Yoon, R., Gold, R., Berlit, P., Jaspert-Grehl, A., Liebetanz, D., Kutschenko, A., Stangel, M., Trebst, C., Baum, P., Bergh, F., Klehmet, J., Meisel, A., Klostermann, F., Oechtering, J., Lehmann, H., Schroeter, M., Hagenacker, T., Mueller, D., Sperfeld, A., Bethke, F., Drory, V., Algom, A., Yarnitsky, D., Murinson, B., Di Muzio, A., Ciccocioppo, F., Sorbi, S., Mata, S., Schenone, A., Grandis, M., Lauria, G., Cazzato, D., Antonini, G., Morino, S., Cocito, D., Zibetti, M., Yokota, T., Ohkubo, T., Kanda, T., Kawai, M., Kaida, K., Onoue, H., Kuwabara, S., Mori, M., Iijima, M., Ohyama, K., Baba, M., Tomiyama, M., Nishiyama, K., Akutsu, T., Yokoyama, K., Kanai, K., van Schaik, I. N., Eftimov, F., Notermans, N. C., Visser, N., Faber, C., Hoeijmakers, J., Rejdak, K., Chyrchel-Paszkiewicz, U., Casanovas Pons, C., Antonia, M., Gamez, J., Salvado, M., Infante, C. Marquez, Benitez, S., Lunn, M., Morrow, J., Gosal, D., Lavin, T., Melamed, I., Testori, A., Ajroud-Driss, S., Menichella, D., Simpson, E., Lai, E. Chi-Ho, Dimachkie, M., Barohn, R. J., Beydoun, S., Johl, H., Lange, D., Shtilbans, A., Muley, S., Ladha, S., Freimer, M., Kissel, J., Latov, N., Chin, R., Ubogu, E., Mumfrey, S., Rao, T., Macdonald, P., Sharma, K., Gonzalez, G., Allen, J., Walk, D., Hobson-Webb, L., Gable, K., De Bleecker, J. L., Robberecht, W., Franques, J., Léger, J. -M., Morales, R. Juntas, Nguento, A., Schrey, Ch., Kamienowski, J., Stelmasiak, Z., Zwolińska, G., Neurology, AII - Infectious diseases, ANS - Neuroinfection & -inflammation, CSL Behring, Neurologian yksikkö, Clinicum, Department of Food and Nutrition, and HUS Neurocenter

Subjects
Research Report, Male, Outcome Assessment, efficacy, Medizin, Chronic inflammatory demyelinating polyneuropathy, CIDP, IVIG, PATH, PRIMA, Neuroscience (all), Neurology (clinical), INFLAMMATORY DEMYELINATING POLYNEUROPATHY, 3124 Neurology and psychiatry, law.invention, Grip strength, 0302 clinical medicine, Randomized controlled trial, law, Interquartile range, hemic and lymphatic diseases, Outcome Assessment, Health Care, 80 and over, Medicine and Health Sciences, Prospective Studies, Chronic Inflammatory Demyelinating, Prospective cohort study, Aged, 80 and over, education.field_of_study, General Neuroscience, Immunoglobulins, Intravenous, Middle Aged, OPEN-LABEL, humanities, 3. Good health, PREVALENCE, Europe, 030220 oncology & carcinogenesis, Cohort, POLYRADICULONEUROPATHY, Female, Intravenous, Polyneuropathy, Life Sciences & Biomedicine, Adult, medicine.medical_specialty, Efficacy, Neuroscience(all), Population, Clinical Neurology, Immunoglobulins, MAINTENANCE TREATMENT, 03 medical and health sciences, Young Adult, Double-Blind Method, Internal medicine, medicine, Journal Article, Humans, Immunologic Factors, INTRAVENOUS IMMUNOGLOBULIN, Aged, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating, education, Science & Technology, business.industry, Neurosciences, 3112 Neurosciences, Research Reports, medicine.disease, PHASE-III, Health Care, cidp, ivig, path, prima, Neurosciences & Neurology, business, 030217 neurology & neurosurgery
Abstract

PRIMA Trial Investigators and the PATH Study Group., Intravenous immunoglobulin (IVIG) is a potential therapy for chronic inflammatory demyelinating polyneuropathy (CIDP). To investigate the efficacy and safety of the IVIG IgPro10 (Privigen) for treatment of CIDP, results from Privigen Impact on Mobility and Autonomy (PRIMA), a prospective, open‐label, single‐arm study of IVIG in immunoglobulin (Ig)‐naïve or IVIG pre‐treated subjects (NCT01184846, n = 28) and Polyneuropathy And Treatment with Hizentra (PATH), a double‐blind, randomized study including an open‐label, single‐arm IVIG phase in IVIG pre‐treated subjects (NCT01545076, IVIG restabilization phase n = 207) were analyzed separately and together (n = 235). Efficacy assessments included change in adjusted inflammatory neuropathy cause and treatment (INCAT) score, grip strength and Medical Research Council (MRC) sum score. Adverse drug reactions (ADRs) and ADRs/infusion were recorded. Adjusted INCAT response rate was 60.7% in all PRIMA subjects at Week 25 (76.9% in IVIG pre‐treated subjects) and 72.9% in PATH. In the pooled cohort (n = 235), INCAT response rate was 71.5%; median time to INCAT improvement was 4.3 weeks. No clear demographic differences were noticed between early (responding before Week 7, n = 148) and late responders (n = 21). In the pooled cohort, median change from baseline to last observation was −1.0 (interquartile range −2.0; 0.0) point for INCAT score; +8.0 (0.0; 20.0) kPa for maximum grip strength; +3.0 (1.0; 7.0) points for MRC sum score. In the pooled cohort, 271 ADRs were reported in 105 subjects (44.7%), a rate of 0.144 ADRs per infusion. This analysis confirms the efficacy and safety of IgPro10, a recently FDA‐approved IVIG for CIDP, in a population of mainly pre‐treated subjects with CIDP [Correction added on 14 March 2019 after first online publication: the INCAT response rate has been corrected.].

Published
2019

45. Comparing the NIS vs. MRC and INCAT sensory scale through Rasch analyses

Author

Draak, Thomas H. P., Vanhoutte, Els K., van Nes, Sonja I., Gorson, Kenneth C., Van der Pol, W.-Ludo, Notermans, Nicolette C., Nobile-Orazio, Eduardo, Lewis, Richard A., Léger, Jean-Marc, Van den Bergh, Peter Y. K., Lauria, Giuseppe, Bril, Vera, Katzberg, Hans, Lunn, Michael P. T., Pouget, Jean, van der Kooi, Anneke J., Hahn, Angelika F., van den Berg, Leonard H., van Doorn, Pieter A., Cornblath, David R., Faber, Catharina G., Merkies, Ingemar S. J., Barreira, A. A., Bennett, D., Hadden, R. D., Hughes, R. A.C., Lunn, M. P.T., Reilly, M. M., van den Berg, L. H., van Doorn, P. A., Faber, C. G., van der Kooi, A. J., Merkies, I. S.J., Notermans, N. C., Raaphorts, J., van Schaik, I. N., de Visser, M., Cats, E. A., Van den Bergh, P. Y.K., Bombelli, F., Costa, R., Franques, J., Léger, J-M., Pouget, J., Bril, V., Hahn, A. F., Katzberg, H., Campanella, A., Devigili, G., Gallia, F., Lauria, G., Nobile-Orazio, E., Padua, L., Cornblath, D. R., Gorson, K. C., Lewis, R. A., Illa, I, Querol, L., and van Nes, S. I.

Published
2015
Full Text
View/download PDF

46. Grip strength comparison in immune-mediated neuropathies: Vigorimeter vs. Jamar

Author

Draak, Thomas H. P., Pruppers, Mariëlle H. J., van Nes, Sonja I., Vanhoutte, Els K., Bakkers, Mayienne, Gorson, Kenneth C., Van der Pol, W.-Ludo, Lewis, Richard. A., Notermans, Nicolette C., Nobile-Orazio, Eduardo, Léger, Jean-Marc, Van den Bergh, Peter Y. K., Lauria, Giuseppe, Bril, Vera, Katzberg, Hans, Lunn, Michael P. T., Pouget, Jean, van der Kooi, Anneke J., van den Berg, Leonard H., van Doorn, Pieter A., Cornblath, David R., Hahn, Angelika F., Faber, Catharina G., Merkies, Ingemar S. J., Barreira, A. A., Bennett, D., Hadden, R. D., Hughes, R. A.C., Lunn, M. P.T., Reilly, M. M., van den Berg, L. H., van Doorn, P. A., Faber, C. G., van der Kooi, A. J., Merkies, I. S.J., Notermans, N. C., Raaphorts, J., van Schaik, I. N., de Visser, M., Cats, E. A., Van den Bergh, P. Y.K., Bombelli, F., Costa, R., Franques, J., Léger, J-M., Pouget, J., Bril, V., Hahn, A. F., Katzberg, H., Campanella, A., Devigili, G., Gallia, F., Lauria, G., Nobile-Orazio, E., Padua, L., Cornblath, D. R., Gorson, K. C., Lewis, R. A., Illa, I, Querol, L., and van Nes, S. I.

Published
2015
Full Text
View/download PDF

47. Outcome measures in MMN revisited: further improvement needed

Author

Pruppers, Mariëlle H. J., Draak, Thomas H. P., Vanhoutte, Els K., Van der Pol, W-Ludo, Gorson, Kenneth C., Léger, Jean-Marc, Nobile-Orazio, Eduardo, Lewis, Richard. A., van den Berg, Leonard H., Faber, Catharina G., Merkies, Ingemar S. J., Barreira, A. A., Bennett, D., Hadden, R. D., Hughes, R. A.C., Lunn, M. P.T., Reilly, M. M., van den Berg, L. H., van Doorn, P. A., Faber, C. G., van der Kooi, A. J., Merkies, I. S.J., Notermans, N. C., Raaphorts, J., van Schaik, I. N., de Visser, M., Cats, E. A., Van den Bergh, P. Y.K., Bombelli, F., Costa, R., Franques, J., Léger, J-M., Pouget, J., Bril, V., Hahn, A. F., Katzberg, H., Campanella, A., Devigili, G., Gallia, F., Lauria, G., Nobile-Orazio, E., Padua, L., Cornblath, D. R., Gorson, K. C., Lewis, R. A., Illa, I, Querol, L., and van Nes, S. I.

Published
2015
Full Text
View/download PDF

48. Impairment measures versus inflammatory RODS in GBS and CIDP: a responsiveness comparison

Author

Vanhoutte, Els K., Draak, Thomas H. P., Gorson, Kenneth C., van Nes, Sonja I., Hoeijmakers, Janneke G. J., Van der Pol, W.-Ludo, Notermans, Nicolette. C., Lewis, Richard A., Nobile-Orazio, Eduardo, Léger, Jean-Marc, Van den Bergh, Peter Y. K., Lauria, Giuseppe, Bril, Vera, Katzberg, Hans, Lunn, Michael P. T., Pouget, Jean, van der Kooi, Anneke J., Hahn, Angelika F., van Doorn, Pieter A., Cornblath, David R., van den Berg, Leonard H., Faber, Catharina G., Merkies, Ingemar S. J., Barreira, A. A., Bennett, D., Hadden, R. D., Hughes, R. A.C., Lunn, M. P.T., Reilly, M. M., van den Berg, L. H., van Doorn, P. A., Faber, C. G., van der Kooi, A. J., Merkies, I. S.J., Notermans, N. C., Raaphorts, J., van Schaik, I. N., de Visser, M., Cats, E. A., Van den Bergh, P. Y.K., Bombelli, F., Costa, R., Franques, J., Léger, J-M., Pouget, J., Bril, V., Hahn, A. F., Katzberg, H., Campanella, A., Devigili, G., Gallia, F., Lauria, G., Nobile-Orazio, E., Padua, L., Cornblath, D. R., Gorson, K. C., Lewis, R. A., Illa, I, Querol, L., and van Nes, S. I.

Published
2015
Full Text
View/download PDF

49. Rasch-ionale for neurologists

Author

Vanhoutte, Els K., Hermans, Mieke C. E., Faber, Catharina G., Gorson, Kenneth C., Merkies, Ingemar S. J., Thonnard, Jean-L., Barreira, A. A., Bennett, D., Hadden, R. D., Hughes, R. A.C., Lunn, M. P.T., Reilly, M. M., van den Berg, L. H., van Doorn, P. A., Faber, C. G., van der Kooi, A. J., Merkies, I. S.J., Notermans, N. C., Raaphorts, J., van Schaik, I. N., de Visser, M., Cats, E. A., Van den Bergh, P. Y.K., Bombelli, F., Costa, R., Franques, J., Léger, J-M., Pouget, J., Bril, V., Hahn, A. F., Katzberg, H., Campanella, A., Devigili, G., Gallia, F., Lauria, G., Nobile-Orazio, E., Padua, L., Cornblath, D. R., Gorson, K. C., Lewis, R. A., Illa, I, Querol, L., and van Nes, S. I.

Published
2015
Full Text
View/download PDF

50. Rasch-built Overall Disability Scale for Multifocal motor neuropathy (MMN-RODS©)

Author

Vanhoutte, Els K., Faber, Catharina G., van Nes, Sonja I., Cats, Elisabeth A., Van der Pol, W.-Ludo, Gorson, Kenneth C., van Doorn, Pieter A., Cornblath, David R., van den Berg, Leonard H., Merkies, Ingemar S. J., Barreira, A. A., Bennett, D., Hadden, R. D., Hughes, R. A.C., Lunn, M. P.T., Reilly, M. M., van den Berg, L. H., van Doorn, P. A., Faber, C. G., van der Kooi, A. J., Merkies, I. S.J., Notermans, N. C., Raaphorts, J., van Schaik, I. N., de Visser, M., Cats, E. A., Van den Bergh, P. Y.K., Bombelli, F., Costa, R., Franques, J., Léger, J-M., Pouget, J., Bril, V., Hahn, A. F., Katzberg, H., Campanella, A., Devigili, G., Gallia, F., Lauria, G., Nobile-Orazio, E., Padua, L., Cornblath, D. R., Gorson, K. C., Lewis, R. A., Illa, I, Querol, L., and van Nes, S. I.

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results